Implementation of a Pharmacist-Led, Long-Acting, Injectable Cabotegravir/Rilpivirine Program for HIV-1 at Health System-Based Clinics in the New York Metropolitan Area [0.03%]
在纽约大都市地区基于卫生系统的诊所中实施药剂师主导的长效注射卡博特格瑞韦/利匹韦林计划以治疗HIV-1感染
Ngan M Nguyen,Rebecca Kavanagh,Martin Gozar et al.
Ngan M Nguyen et al.
Long-acting cabotegravir/rilpivirine (LA-CAB/RPV) is the first complete injectable antiretroviral for patients living with HIV. To facilitate patient access to long-acting injectable treatment, a system-wide, pharmacist-led, LA-CAB/RPV tran...
HIV Pre-Exposure Prophylaxis Uptake Among High-Risk Population in Sub-Saharan Africa: A Systematic Review and Meta-Analysis [0.03%]
撒哈拉以南非洲高危人群中HIV暴露前预防的使用情况：系统评价和荟萃分析
Henry Nagai,Augustine Ankomah,Kamil Fuseini et al.
Henry Nagai et al.
Globally, 38.4 million people are affected by the human immunodeficiency virus (HIV) pandemic, and more than 2.5 million new HIV infections occur yearly. HIV pre-exposure prophylaxis (PrEP) has been widely recognized as a potential way to p...
Meta-Analysis
AIDS patient care and STDs. 2024 Feb;38(2):70-81. DOI:10.1089/apc.2023.0117 2024
Latent Profile Analysis of Cognitive Performance and Depressive Symptoms Among People with HIV [0.03%]
HIV感染者中认知表现和抑郁症状的潜在轮廓分析
Maulika Kohli,Lillian Ham,Rowan Saloner et al.
Maulika Kohli et al.
Depression and cognitive impairment are prevalent conditions among people with HIV (PWH), likely attributable to shared causes and common risk factors. Identifying subtypes of PWH with similar patterns of neurocognitive impairment (NCI) and...
Long-Acting Injectable Antiretrovirals for HIV Treatment: A Multi-Site Qualitative Study of Clinic-Level Barriers to Implementation in the United States [0.03%]
长效注射抗逆转录病毒药物用于HIV治疗：美国多地点定性研究诊所层面的实施障碍
Tara McCrimmon,Lauren F Collins,Amaya Perez-Brumer et al.
Tara McCrimmon et al.
Long-acting injectable antiretroviral therapy (LAI ART) has the potential to address adherence obstacles associated with daily oral ART, leading to enhanced treatment uptake, adherence, and viral suppression among people living with HIV (PL...
Multicenter Study
AIDS patient care and STDs. 2024 Feb;38(2):61-69. DOI:10.1089/apc.2023.0248 2024
Intention to Use Different Formulations of Longer Acting HIV Pre-Exposure Prophylaxis Among Transgender and Gender Expansive Individuals: The Roles of Social Vulnerability and Medical Mistrust [0.03%]
跨性别和性别多样化个体使用不同配方的长效HIV暴露前预防药物的意愿：社会脆弱性和医疗不信任的作用
Phillip W Schnarrs,Julie Zuñiga,Gabrielle Benitez et al.
Phillip W Schnarrs et al.
In 2012, the Federal Drug Administration approved daily oral pre-exposure prophylaxis (PrEP) for HIV prevention in adults. Longer acting injectable PrEP (LA PrEP) has been approved and other formulations are in development. A successful LA ...
Electronic Partner Notification for Sexually Transmitted Infections: A Qualitative Assessment of Patient, Clinical Staff, and State Field Epidemiologist Perspectives [0.03%]
性传播感染的电子伴侣通知：患者、临床工作人员和州现场流行病学家观点的定性评估
Surabhi Iyer,Dani L Zionts,Christina Psaros et al.
Surabhi Iyer et al.
In Massachusetts (MA), partner notification is routinely offered for new HIV and infectious syphilis cases, but there are no formal partner notification services for gonorrhea and chlamydia. Electronic partner notification (ePN), which allo...
Demographics, Trends, and Clinical Characteristics of HIV Pre-Exposure Prophylaxis Recipients and People Newly Diagnosed with HIV from Large Electronic Health Records in Florida [0.03%]
来自佛罗里达大型电子健康记录的HIV暴露前 prophylaxis 接受者和新诊断出患有 HIV 的人的流行病学、趋势和临床特征
Yiyang Liu,Khairul A Siddiqi,Hwayoung Cho et al.
Yiyang Liu et al.
Florida is one of the HIV epicenters with high incidence and marked sociodemographic disparities. We analyzed a decade of statewide electronic health record/claims data-OneFlorida+-to identify and characterize pre-exposure prophylaxis (PrEP...
A Systematic Review of the Impact of HIV-Related Stigma and Serostatus Disclosure on Retention in Care and Antiretroviral Therapy Adherence Among Women with HIV in the United States/Canada [0.03%]
HIV感染女性相关羞辱和病毒状态揭发对治疗和抗逆转录病毒治疗方法遵从性的影响的系统回顾研究报告(研究范围限于美国/加拿大)
Ekpereka Sandra Nawfal,Aaliyah Gray,Diana M Sheehan et al.
Ekpereka Sandra Nawfal et al.
This systematic review explores the roles of HIV stigma and disclosure of HIV serostatus in antiretroviral therapy (ART) adherence and retention in care (RIC) among women with HIV (WHIV) in the United States and Canada. We conducted a syste...
Response to: Implementation Facilitators and Barriers for Primary Care Providers Prescribing Daily Oral PrEP to Adolescents in the United States (re: DOI: 10.1089/apc.2023.0090) [0.03%]
对《美国初级保健提供者为青少年开具每日口服PrEP的实施促进因素和障碍》(关于DOI: 10.1089/apc.2023.0090的回应)
Stephanie Gieseken,Gladys Ibanez
Stephanie Gieseken
Anal Dysplasia Screening in People Living with HIV: Long-Term Follow-Up in a Large Cohort from Northwest Spain [0.03%]
西班牙西北部一大型队列中HIV感染人群的肛门鳞状上皮内病变长期随访研究
Alexandre Pérez-González,Silvia Rodríguez-Rivero,Pilar Fernández-Veiga et al.
Alexandre Pérez-González et al.
Anal squamous cell carcinoma (SCC) is not a common disease in the general population, although its incidence is higher in people living with human immunodeficiency virus (PLWH). Anal SCC is caused by human papillomavirus (HPV) infection and...